Clinical trial
Early Ileostomy Closure Following Restorative Proctectomy for Rectal Cancer Patients: A North American Multicenter Randomized-Controlled Trial (RCT)
NCT05027737 is registered in ClinicalTrials.gov with Jewish General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Ileostomy Closure Following Restorative Proctectomy for Rectal Cancer Patients: A North American Multicenter Randomized-Controlled Trial (RCT)
- Lead sponsor
- Jewish General Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 22, 2022
- Completion date
- September 1, 2026
- Enrollment
- 118 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
ileostomy - stoma, rectal cancer